The estimated Net Worth of James F. Hinrichs is at least $571 Tysiąc dollars as of 24 May 2024. Mr. Hinrichs owns over 9,603 units of Orthofix Medical Inc stock worth over $296,270 and over the last 11 years he sold OFIX stock worth over $0. In addition, he makes $274,981 as Independent Director at Orthofix Medical Inc.
James has made over 11 trades of the Orthofix Medical Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 9,603 units of OFIX stock worth $428,294 on 24 May 2024.
The largest trade he's ever made was buying 40,000 units of Orthofix Medical Inc stock on 15 November 2021 worth over $151,200. On average, James trades about 3,220 units every 82 days since 2014. As of 24 May 2024 he still owns at least 17,027 units of Orthofix Medical Inc stock.
You can see the complete history of Mr. Hinrichs stock trades at the bottom of the page.
James F. Hinrichs is Independent Director of the Company since April 2014. From May 2018 through July 2019, he served as Chief Financial Officer of Cibus, a privately-held agricultural biotech company. From April 2015 to October 2017, he served as Executive Vice President and Chief Financial Officer of Alere Inc, a publicly traded diagnostic company, prior to its sale to Abbott Labs. From December 2010 through March 2015, he served as Chief Financial Officer of CareFusion Corporation, a publicly traded medical technology company, prior to its sale to Becton Dickinson. He previously served as CareFusion’s Senior Vice President, Global Customer Support, from January 2010 to December 2010, and as its Senior Vice President, Controller, from January 2009 to January 2010. Prior to joining CareFusion when it was spun off from Cardinal Health, Inc., he worked since 2004 at Cardinal Health in various positions including Executive Vice President and Corporate Controller of Cardinal Health, and as Executive Vice President and Chief Financial Officer of its Healthcare Supply Chain Services segment. He joined Cardinal Health following over a decade of finance and marketing roles at Merck & Co. He holds undergraduate and graduate degrees in business from Carnegie Mellon University. Mr. Hinrichs has served as a director of Integer Holdings Corporation since February 2018.
As the Independent Director of Orthofix Medical Inc, the total compensation of James Hinrichs at Orthofix Medical Inc is $274,981. There are 10 executives at Orthofix Medical Inc getting paid more, with Jon Serbousek having the highest compensation of $4,076,200.
James Hinrichs is 52, he's been the Independent Director of Orthofix Medical Inc since 2014. There are 16 older and 1 younger executives at Orthofix Medical Inc. The oldest executive at Orthofix Medical Inc is Ronald Matricaria, 77, who is the Independent Chairman of the Board.
James's mailing address filed with the SEC is 3052 ORCHARD DRIVE, , SAN JOSE, CA, 95134.
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth oraz Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
Orthofix Medical Inc executives and other stock owners filed with the SEC include: